All 3 models highlight the $5.8B
OXY's $9.7B OxyChem divestiture to Berkshire Hathaway has closed, delivering $5.8B in debt reduction and sharpening focus on high-margin Permian Basin production — a structural re-rating catalyst that the market has not yet fully priced. With Zacks upgrading to Strong-Buy, a $74 price target from American Banking News, and Berkshire holding 26.86%, institutional support is robust. A pullback to the $62–$63 zone — still well above the $58.10 support and both key daily SMAs — offers a technically sound long entry toward the $67.45 resistance and beyond.
OXY has rallied ~80% off its 52-week low and is now pressing against the $67.45 all-time resistance zone while the weekly RSI sits at an overbought 75.95 and is already falling — a classic exhaustion signal. The daily MACD histogram has turned negative (reversing), the stock is trading well above its 30-min SMA50 ($64.07), and the cross-asset picture is contradictory: USO surged +6.62% over 5 sessions while OXY fell -4.03%, suggesting the equity is already pricing in a geopolitical premium that crude itself is only now catching up to. A mean-reversion toward the $57–$58 support cluster is the path of least resistance as momentum fades and the macro regime remains neutral.
Thesis Competition: BULL case won (45% vs 44%).
This is a pullback-buy / trend-continuation long: OXY still trades above its 20-day, 50-day, and weekly 20-SMA, recent volume is running 16% above the prior 5-day average, and the $9.7B OxyChem sale has already driven roughly $5.8B of debt reduction, improving the balance-sheet story after another EPS and production beat. If the stock mean-reverts back with crude after this sector digestion, a retest of $67.45 should open a catch-up move toward the upper 70s over the next several weeks.
OXY is setting up as a short-on-strength reversal rather than a clean oil-beta breakout: the stock sits just under 52-week resistance at $67.45 with weekly RSI 75.95 rolling over, daily MACD turning down, and 5-day relative weakness versus both USO (+6.62%) and SPY (+4.01%) showing that crude strength is not translating into equity sponsorship. After a 58% YTD run and a stretch well above both daily and weekly trend averages, rebounds into the $65- $67 supply zone are more likely to fail and mean-revert toward the low-50s volume nodes and then the upper-40s over the next several weeks.
Thesis Competition: BULL case won (56% vs 52%).
OXY offers a compelling long setup with strong fundamentals from $5.8B debt reduction and consistent earnings beats, combined with technical support above SMA20 at $60.29. The research desk's bullish thesis on Bab el-Mandeb geopolitical tail risk provides additional upside catalyst, while the stock's recent under performance vs oil creates a catch-up opportunity toward resistance at $67.45.
OXY shows technical divergence with oil (USO +6.62% vs OXY -4.03% over 5 sessions) and approaches key resistance at $67.45 after an 18.1% run above its 50-day SMA. The CEO transition creates execution uncertainty, while RSI at 63.38 on daily timeframe suggests overbought conditions ripe for mean reversion toward the $58.10 support level.
Thesis Competition: BULL case won (49% vs 47%).